# SODIUM BICARBONATE
> **NDA218524** · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2026-08-14
## Drug
- **FDA Application Number:** NDA218524
- **Application type:** New Drug Application
- **Brand name:** SODIUM BICARBONATE
- **Generic name:** SODIUM BICARBONATE
- **Active ingredients:** SODIUM BICARBONATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BAXTER HLTHCARE CORP
- **Manufacturer:** Baxter Healthcare Corporation
- **First approval:** 2026-08-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218524)
---
*MORVS · CC0 1.0*